Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
arena pharmaceuticals
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cardiovascular disease
clinical trials
colorectal cancer
detroit blog main
detroit top stories
eisai
europe blog main
europe top stories
fda
indiana blog main
indiana top stories
life sciences
lorcaserin
lung cancer
national
national blog main
national top stories
new york blog main
new york top stories
obsesity
orexigen therapeutics
pancreatic cancer
product recalls
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
What
marketing
2
×
medicine
2
×
patients
2
×
analysed
benefits
big
broken
cancer
design
designed
dlc
drug
drugs
eisai
evil
exaggerate
favour
fda
flags
flawed
higher
hopelessly
incidence
isn't
lorcaserin
loss
malpractice
manufacture
market
numbers
people
pharma
poorly
post
produce
pulls
results
risks
small
studies
Language
unset
Current search:
marketing
×
medicine
×
patients
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@eurogamer.net
7 years ago
Even with the Marketing and Malpractice DLC, Big Pharma just isn't evil enough